Literature DB >> 9503182

Long-term outcome of patients with incomplete vs complete revascularization after multivessel PTCA. A report from the NHLBI PTCA Registry.

M G Bourassa1, W Yeh, R Holubkov, G Sopko, K M Detre.   

Abstract

BACKGROUND: Incomplete revascularization is frequently the goal as well as the final outcome in patients with multivessel coronary disease undergoing PTCA. However, the long-term impact of incomplete revascularization is not known and this common PTCA strategy deserves further scrutiny. METHODS AND
RESULTS: Complete revascularization was achieved in 132 of 757 patients with multivessel disease in the 1985-86 NHLBI PTCA Registry. Compared to patients in whom complete revascularization was achieved, patients with incomplete revascularization were older (P < 0.05), more likely to be females (P < 0.05) and to have recent myocardial infarction (P < 0.05), unstable angina (P < 0.001), and urgent or emergent PTCA (P < 0.001). Early death, Q wave myocardial infarction and CABG rates were higher in patients with incomplete than in those with complete revascularization [significantly different (P < 0.05) only for emergency and elective CABG]. At 9 years, nearly twice as many patients with incomplete revascularization experienced recurrent angina (19% vs 10% for patients with complete revascularization, P < 0.05). Patients with complete revascularization were more likely to undergo repeat PTCA than those with incomplete revascularization (40% vs 30%, P < 0.05). Patients with incomplete revascularization were more likely to undergo CABG than patients with complete revascularization (32% vs 14%, P < 0.001; adjusted risk 2.56, 95% CI 1.60, 4.10). Among patients with incomplete revascularization, those in whom PTCA was intended but not attempted had the highest early event rates and late CABG rates. Finally, the adjusted risk of dying, having a Q wave myocardial infarction, recurrent angina or repeat PTCA was not different at 9-year follow-up among patients with and without complete revascularization.
CONCLUSIONS: Complete revascularization achieved by PTCA reduces late occurrence of CABG, but not adjusted rates of death, Q wave myocardial infarction, recurrent angina, and repeat PTCA in patients with multivessel coronary disease. These data tend to support the PTCA strategy of incomplete revascularization in patients with multivessel disease when complete revascularization is not feasible or not planned before the procedure.

Entities:  

Mesh:

Year:  1998        PMID: 9503182     DOI: 10.1053/euhj.1997.0574

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  6 in total

1.  Impact of incomplete revascularization on long-term mortality after coronary stenting.

Authors:  Chuntao Wu; Anne-Marie Dyer; Spencer B King; Gary Walford; David R Holmes; Nicholas J Stamato; Ferdinand J Venditti; Samin K Sharma; Icilma Fergus; Alice K Jacobs; Edward L Hannan
Journal:  Circ Cardiovasc Interv       Date:  2011-10-04       Impact factor: 6.546

2.  Potential shift from coronary bypass surgery to percutaneous coronary intervention for multivessel disease and its economic impact in the drug-eluting stent era.

Authors:  Frédéric Poulin; Stéphane Rinfret; François Gobeil
Journal:  Can J Cardiol       Date:  2007-12       Impact factor: 5.223

3.  Differential Clinical Outcomes Between Angiographic Complete Versus Incomplete Coronary Revascularization, According to the Presence of Chronic Kidney Disease in the Drug-Eluting Stent Era.

Authors:  Jihoon Kim; Joo Myung Lee; Ki Hong Choi; Tae-Min Rhee; Doyeon Hwang; Jonghanne Park; Chul Ahn; Taek Kyu Park; Jeong Hoon Yang; Young Bin Song; Jin-Ho Choi; Joo-Yong Hahn; Seung-Hyuk Choi; Hyeon-Cheol Gwon
Journal:  J Am Heart Assoc       Date:  2018-02-15       Impact factor: 5.501

4.  Ten-year all-cause death after percutaneous or surgical revascularization in diabetic patients with complex coronary artery disease.

Authors:  Rutao Wang; Patrick W Serruys; Chao Gao; Hironori Hara; Kuniaki Takahashi; Masafumi Ono; Hideyuki Kawashima; Neil O'leary; David R Holmes; Adam Witkowski; Nick Curzen; Francesco Burzotta; Stefan James; Robert-Jan van Geuns; Arie Pieter Kappetein; Marie-Angele Morel; Stuart J Head; Daniel J F M Thuijs; Piroze M Davierwala; Timothy O'Brien; Valentin Fuster; Scot Garg; Yoshinobu Onuma
Journal:  Eur Heart J       Date:  2021-12-28       Impact factor: 29.983

5.  Impact of Residual SYNTAX Score and Its Derived Indexes on Clinical Outcomes after Percutaneous Coronary Intervention: Data from a Large Single Center.

Authors:  Ying Song; Zhan Gao; Xiao-Fang Tang; Ping Jiang; Jing-Jing Xu; Yi Yao; Jian-Xin Li; Xue-Yan Zhao; Shu-Bin Qiao; Yue-Jin Yang; Run-Lin Gao; Bo Xu; Jin-Qing Yuan
Journal:  Chin Med J (Engl)       Date:  2018-06-20       Impact factor: 2.628

6.  Objectifying the level of incomplete revascularization by residual SYNTAX score and evaluating the impact of incomplete revascularization on exercise tolerance in patients with coronary atherosclerotic heart disease treated by percutaneous coronary intervention.

Authors:  Lin Xue; Danjie Guo; Lan Wang; Chengfu Cao; Qi Li; Shangzhi Zou
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.